Overview

An Open-label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With Capecitabine

Status:
Terminated

Trial end date:
2007-09-01

Target enrollment:

Participant gender:

Summary

The overall purpose of this study is to compare the efficacy, safety and tolerability of indisulam in combination with capecitabine (IC) versus capecitabine (C) monotherapy in patients with metastatic breast cancer who have previously been treated with an anthracycline and a taxane.

Phase:

Phase 2

Details

Lead Sponsor:

Eisai Limited

Treatments:

Capecitabine
N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide